Health care biotech companies by P/E ratio

Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.

Exelixis has the lowest figure of the 9 health care biotech companies ranked by P/E ratio, at 19.7, followed by Neurocrine Biosciences (23.2) and Halozyme Therapeutics (23.3). Figures as of 19 Nov 2026, 23:33 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
9
Lowest
Exelixis19.7
Median
26.8
Combined market value
PLN 3.35T
Countries
5
Not ranked
15no P/E ratio on file

Market values as of .

All countries
Health Care
Biotech
PLN
Clear filters
Health care biotech companies by P/E ratio
#CompanyP/E ↑Market capPriceToday1 yearPrice, 30 daysCountry
1ExelixisEXEL · Health Care19.7PLN 64.9BPLN 266.04 3.60% down 63% up United States
2Neurocrine BiosciencesNBIX · Health Care23.2PLN 64.1BPLN 632.83 3.85% down 17% up United States
3Halozyme TherapeuticsHALO · Health Care23.3PLN 42.9BPLN 376.00 2.88% down 39% up United States
4AmgenAMGN · Health Care25.4PLN 959.3BPLN 1,773.40 1.14% down 32% up United States
5QiagenQGEN · Health Care26.8PLN 41.4BPLN 200.57 0.14% up 9% up Netherlands
6argenxARGX · Health Care32.6PLN 239.4BPLN 3,807.07 0.08% up 2% up Belgium
7Krystal BiotechKRYS · Health Care42.9PLN 37.8BPLN 1,276.32 0.15% up 54% up United States
8Bio-TechneTECH · Health Care66.7PLN 46.2BPLN 293.80 0.07% down 24% up United States
9BiogenBIIB · Health Care107PLN 147.6BPLN 998.73 1.70% down 49% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0413 PLN). 15 companies have no P/E ratio on file and are not ranked here.

Questions and answers

Which health care biotech companies have the lowest P/E ratio?

Exelixis (19.7), Neurocrine Biosciences (23.2) and Halozyme Therapeutics (23.3) have the lowest P/E ratio of the 9 health care biotech companies ranked here as of 19 Nov 2026, 23:33 UTC.

How many health care biotech companies are in this ranking?

9 are ranked by P/E ratio. 15 more have no P/E ratio on file and are left out rather than ranked at zero.

What are these health care biotech companies worth together?

The 9 health care biotech companies ranked by P/E ratio have a combined market value of PLN 3.35T as of 19 Nov 2026, 23:33 UTC.

What does ranking by P/E ratio measure?

Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.

Cite this page

Funkfolio, “Health care biotech companies by P/E ratio”, data as of 19 November 2026. https://funkfolio.com/companies/category/biotech?sector=health-care&by=pe-ratio

Underlying data: Yahoo Finance; SEC EDGAR.